Survival among Dually Infected HIV Patients Compared to HIV-1 Mono-Infected Patients Receiving ART in Senegal: A Twelve-Year Cohort Study
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 1
Abstract
In West Africa, HIV-2 single infection (HIV-2s) and HIV-1 + HIV-2 dual infection (HIV-D) remain endemic but their morbidity is progressively decreasing. Among HIV-D infected patients receiving antiretroviral therapy (ART), data on mortality are very scarce. The purpose of this analysis was to compare survival of HIV-D infected with that of HIV-1 singly infected (HIV-1s) patients over twelve years of follow up after ART initiation.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP353889
- DOI 10.23937/2469-567X/1510022
- Views 105
- Downloads 0
Elimination of Mother-to-Child Transmission of HIV in Democratic Republic of Congo: Implementation of "Test &Treat" Approach at Primary Health Centers
Background: The "Test & Treat" approach, also called option B+, using combination antiretroviral treatment (cART) for prevention of mother-to-child transmission (PMTCT) has been very effective in controlled clinical tria...
PrEP Works, But Only When You [Have Access to] Take it: Improving PrEP Access for Young People in Chicago and Philadelphia
The 2012 United States Food and Drug Administration approval of Tenofovir/Emtricitabine for HIV pre-exposure prophylaxis (PrEP) has added a highly effective, safe biomedical option to the HIV prevention toolbox. In the U...
The Monitoring of Lymphocyte Populations may be Optional in Patients with Suppressed Viremia: A Two Years Observational Study
The determination of lymphocyte populations (LPs) traditionally has been included in the routine follow-up of HIV-infected patients as an indicator of the degree of immune suppression and of the need to start treatment,...
Differential Risky Behaviors among HIV Positive and HIV Negative People
In the past years, HIV prevention efforts have increased with focus on people living with HIV and AIDS (PLWHA) in addition to addressing risk reduction efforts targeting HIV-uninfected individuals. HIV prevalence is 6.3%...
p53 Expression Activation of HIV-1 Latency in U1 Cells
Latent infection is a major barrier for cure of HIV-1 infection. HIV-1 is capable of establishing latency when its host cells undergo apoptosis and initiate replication in response to this effect. HIV infection results i...